Capreomycin, a polypeptide antibiotic complex of 4 microbiologically active components, is an antituberculosis agent. Capreomycin is used in conjunction with other antituberculosis agents in the treatment of clinical tuberculosis.
Antituberculosis drugs
Aminosalicylic Acid
Aminosalicylic acid is used in conjunction with other antituberculosis agents in the treatment of clinical tuberculosis. The drug is designated an orphan drug by the US Food and Drug Administration (FDA) for use in the treatment of tuberculosis. These regimens have a minimum duration of 6 months (26 weeks), and consist of an initial intensive phase (2 months) and a continuation phase (usually either 4 or 7 months). Aminosalicylic acid is considered a second-line antituberculosis agent for use in these regimens.
Antituberculosis Agents General Statement
Antituberculosis agents are antibiotics and synthetic anti-infectives used in the treatment of tuberculosis and other diseases caused by organisms of the genus Mycobacterium. Isoniazid, rifampin, ethambutol, and pyrazinamide are the drugs used most frequently in the treatment of tuberculosis and are considered first-line agents for use in antituberculosis regimens.